Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

Nature Reviews Cancer

Volumn 7, Issue 4, 2007, Pages 270-280

  Matsuoka, Masao ^a   Jeang, Kuan Teh ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; ONCOPROTEIN; TAX PROTEIN; VIRUS RNA;

ANEUPLOIDY; CELL TRANSFORMATION; DNA DAMAGE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; T CELL LEUKEMIA; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANEUPLOIDY; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DNA DAMAGE; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MITOSIS; MODELS, BIOLOGICAL;

EID: 33947578030     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc2111     Document Type: Review

References (148)

1. Takatsuki, K. Discovery of adult T-cell leukemia. Retrovirology 2, 16 (2005).
2. Gallo, R. C. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2, 17 (2005).
3. Yoshida, M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24, 5931-5937 (2005).
4. Grassmann, R., Aboud, M. & Jeang, K. T. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976-5985 (2005).
5. Van, D. S., Salemi, M. & Vandamme, A. M. Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes. Mol. Biol. Evol. 18, 661-671 (2001).
6. Wolfe, N. D. et al. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc. Natl Acad. Sci. USA 102, 7994-7999 (2005).
7. Calattini, S. et al. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2, 30 (2005).
8. Proietti, F. A., Carneiro-Proietti, A. B., Catalan-Soares, B. C. & Murphy, E. L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058-6068 (2005).
9. Arisawa, K. et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int. J. Cancer 85, 319-324 (2000).
10. Bangham, C. R. & Osame, M. Cellular immune response to HTLV-1. Oncogene 24, 6035-6046 (2005).
11. Matsuoka, M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2, 27 (2005).
12. Yamaguchi, K. et al. Concurrence of lymphoma type adult T-cell leukemia in three sisters. Cancer 56, 1688-1690 (1985).
13. Etoh, K. et al. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors. Int. J. Cancer 81, 859-864 (1999).
14. Karube, K. et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol. 126, 81-84 (2004).
15. + adult T cell leukemia cells. Int. Immunol. 18, 269-277 (2006).
16. Feuer, G. et al. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo. J. Virol. 70, 4038-4044 (1996). This showed the first evidence that HTLV-1 can infect haematopoietic stem cells, with implications for the cell of origin of ATL.
17. Wencker, M., Sausse, C., Derse, D., Gazzolo, L. & Duc, D. M. Human T-cell leukemia virus type 1 tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes. J. Virol. 81, 301-308 (2007).
18. Hasegawa, H. et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nature Med. 12, 466-472 (2006).
19. Igakura, T. et al. Spread of HTLVI between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299, 1713-1716 (2003). Provided mechanistic insights into the cell-cell spread of HTLV-1.
20. Barnard, A. L., Igakura, T., Tanaka, Y., Taylor, G. P. & Bangham, C. R. Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood 106, 988-995 (2005).
21. Nejmeddine, M., Barnard, A. L., Tanaka, Y., Taylor, G. P. & Bangham, C. R. Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 280, 29653-29660 (2005).
22. Tanaka, Y., Fukudome, K., Hayashi, M., Takagi, S. & Yoshie, O. Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines. Int. J. Cancer 60, 554-561 (1995).
23. Tanaka, Y., Hayashi, M., Takagi, S. & Yoshie, O. Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses. J. Virol. 70, 8508-8517 (1996).
24. Valentin, H. et al. Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein. J. Virol. 71, 8522-8530 (1997).
25. Doi, K. et al. Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. Blood 106, 1048-1053 (2005).
26. Wattel, E., Vartanian, J. P., Pannetier, C. & Wain-Hobson, S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69, 2863-2868 (1995).
27. Etoh, K. et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 57, 4862-4867 (1997).
28. Cavrois, M. et al. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene 17, 77-82 (1998).
29. Taylor, G. P. et al. Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology 3, 63 (2006).
30. Miyazato, P. et al. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice. J. Virol. 80, 10683-10691 (2006).
31. Van, D. S. et al. The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. Mol. Biol. Evol. 21, 603-611 (2004).
32. Manel, N. et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449-459 (2003). Identified a cell-surface receptor for HTLV-1.
33. Takenouchi, N. et al. GLUT1 Is Not the Primary Binding Receptor but Is Associated with Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1. J. Virol. 81, 1506-1510 (2007).
34. Yasunaga, J. et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 97, 3177-3183 (2001).
35. Collins, N. D. et al. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91, 4701-4707 (1998).
36. Silverman, L. R., Phipps, A. J., Montgomery, A., Ratner, L. & Lairmore, M. D. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 78, 3837-3845 (2004).
37. Younis, I., Yamamoto, B., Phipps, A. & Green, P. L. Human T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo. J. Virol. 79, 14473-14481 (2005).
38. Hiraragi, H. et al. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J. Virol. 80, 3469-3476 (2006).
39. Ding, W. et al. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J. Virol. 75, 7672-7682 (2001).
40. Johnson, J. M. et al. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J. Virol. 75, 6086-6094 (2001).
41. Kim, S. J., Nair, A. M., Fernandez, S., Mathes, L. & Lairmore, M. D. Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J. Immunol. 176, 5463-5470 (2006).
42. Nicot, C. et al. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nature Med. 10, 197-201 (2004).
43. Zhang, W., Nisbet, J. W., Bartoe, J. T., Ding, W. & Lairmore, M. D. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J. Virol. 74, 11270-11277 (2000).
44. Akagi, T., Ono, H. & Shimotohno, K. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood 86, 4243-4249 (1995). Gave an early insight into the role of Tax in T-cell immortalization.
45. Furukawa, Y., Kubota, R., Tara, M., Izumo, S. & Osame, M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood 97, 987-993 (2001). Presented evidence consistent with Tax being dispensable for the maintenance of ATL transformation.
46. Takeda, S. et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 109, 559-567 (2004).
47. Koiwa, T. et al. 5′-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 76, 9389-9397 (2002).
48. Taniguchi, Y. et al. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2, 64 (2005).
49. Tamiya, S. et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 88, 3065-3073 (1996). Presented evidence supporting the hypothesis that Tax is not needed for the maintenance of cellular transformation.
50. Duensing, S. & Munger, K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int. J. Cancer 109, 157-162 (2004).
51. Kasai, T. & Jeang, K. T. Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T-cells. Retrovirology 1, 7 (2004).
52. Kuo, Y. L. & Giam, C. Z. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J. 25, 1741-1752 (2006).
53. Matsuoka, M. & Jeang, K. T. Human T-cell leukemia virus type I at age 25: a progress report. Cancer Res. 65, 4467-4470 (2005).
54. Song, G., Ouyang, G. & Bao, S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell Mol. Med. 9, 59-71 (2005).
55. Li, J. et al. PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J. Cell Biol. 165, 77-86 (2004).
56. Jeong, S. J., Pise-Masison, C. A., Radonovich, M. F., Park, H. U. & Brady, J. N. Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 24, 6719-6728 (2005). Shows the importance of Akt signaling in HTLV-1 transformation.
57. Peloponese, J. M. Jr. & Jeang, K. T. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 281, 8927-8938 (2006).
58. Ikezoe, T. et al. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk. Res. 26 September 2006 [Epub ahead of print].
59. Sun, S. C. & Yamaoka, S. Activation of NF-κB by HTLVI and implications for cell transformation. Oncogene 24, 5952-5964 (2005).
60. Iha, H. et al. Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα: implications for stimulus-specific interruption of oncogenic signaling. Oncogene 22, 8912-8923 (2003).
61. Xiao, G. et al. Retroviral oncoprotein Tax induces processing of NFκB2/p100 in T cells: evidence for the involvement of IKKα. EMBO J. 20, 6805-6815 (2001). Provided insight into the activation of NFκB by HTLV-1 Tax.
62. Higuchi, M. et al. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-κB activation. Retrovirology 2, 29 (2005).
63. Hironaka, N. et al. Tax-independent constitutive IκB kinase activation in adult T-cell leukemia cells. Neoplasia. 6, 266-278 (2004).
64. Neuveut, C. et al. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol. Cell Biol. 18, 36-32 (1998).
65. Schmitt, I., Rosin, O., Rohwer, P., Gossen, M. & Grassmann, R. Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J. Virol. 72, 633-640 (1998). One of the initial reports that demonstrated a role for Tax in accelerating cell-cycle progression.
66. Akagi, T., Ono, H. & Shimotohno, K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene 12, 1645-1652 (1996).
67. Santiago, F. et al. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J. Virol. 73, 9917-9927 (1999).
68. Iwanaga, R., Ohtani, K., Hayashi, T. & Nakamura, M. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 20, 2055-2067 (2001).
69. Haller, K. et al. Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol. Cell Biol. 22, 3327-3338 (2002).
70. Fraedrich, K., Muller, B. & Grassmann, R. The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix. Retrovirology 2, 54 (2005).
71. Kehn, K. et al. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 24, 525-540 (2005).
72. Lemasson, I., Thebault, S., Sardet, C., Devaux, C. & Mesnard, J. M. Activation of E2F-mediated transcription by human T-cell leukemia virus type I Tax protein in a p16(INK4A)-negative T-cell line. J. Biol. Chem. 273, 23598-23604 (1998).
73. Suzuki, T., Narita, T., Uchida-Toita, M. & Yoshida, M. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Virology 259, 384-391 (1999).
74. Riou, P., Bex, F. & Gazzolo, L. The human T cell leukemia/ lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors. J. Biol. Chem. 275, 10551-10560 (2000).
75. Low, K. G. et al. Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. J. Virol. 71, 1956-1962 (1997).
76. Suzuki, T., Kitao, S., Matsushime, H. & Yoshida, M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15, 1607-1614 (1996).
77. Kehn, K. et al. The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology 1, 6 (2004).
78. Lee, S. S., Weiss, R. S. & Javier, R. T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA 94, 6670-6675 (1997). The first report on oncoproteins that contain a PBM domain, which is used to inactivate the PDZ-containing tumour suppressor DLG1.
79. Suzuki, T., Ohsugi, Y., Uchida-Toita, M., Akiyama, T. & Yoshida, M. Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control. Oncogene 18, 5967-5972 (1999).
80. Woods, D. F. & Bryant, P. J. The discs-large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions. Cell 66, 451-464 (1991).
81. Matsumine, A. et al. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 272, 1020-1023 (1996).
82. Ishidate, T., Matsumine, A., Toyoshima, K. & Akiyama, T. The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene 19, 365-372 (2000).
83. Hirata, A. et al. PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein augments the transforming activity in a rat fibroblast cell line. Virology 318, 327-336 (2004).
84. Ishioka, K. et al. Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein. Retrovirology 3, 71 (2006).
85. Endo, K. et al. Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax. J. Virol. 76, 2648-2653 (2002).
86. Rasnick, D. Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy. Cancer Genet. Cytogenet. 136, 66-72 (2002).
87. Kasai, T., Iwanaga, Y., Iha, H. & Jeang, K. T. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J. Biol. Chem. 277, 5187-5193 (2002). Presents data that show that ATL cells have a mitotic spindle assembly checkpoint defect.
88. Nigg, E. A. Centrosome aberrations: cause or consequence of cancer progression? Nature Rev. Cancer 2, 815-825 (2002).
89. Pihan, G. A. et al. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 61, 2212-2219 (2001).
90. Schneeweiss, A. et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int. J. Cancer 107, 346-352 (2003).
91. Salisbury, J. L., D'Assoro, A. B. & Lingle, W. L. Centrosome amplification and the origin of chromosomal instability in breast cancer. J. Mammary Gland. Biol. Neoplasia 9, 275-283 (2004).
92. Duensing, S. & Munger, K. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins. Prog. Cell Cycle Res. 5, 383-391 (2003).
93. Forgues, M. et al. Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol. Cell Biol. 23, 5282-5292 (2003).
94. Ching, Y. P., Chan, S. F., Jeang, K. T. & Jin, D. Y. The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat. Cell Biol. 8, 717-724 (2006). Showed details of the mechanism of centrosomal amplification in ATL cells.
95. Peloponese, J. M. Jr, Haller, K., Miyazato, A. & Jeang, K. T. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc. Natl Acad. Sci. USA 102, 18974-18979 (2005).
96. Nitta, T. et al. Centrosome amplification in adult T-cell leukemia and human T-cell leukemia virus type 1 Tax-induced human T cells. Cancer Sci. 97, 836-841 (2006).
97. Kamihira, S. et al. DNA aneuploidy of adult T-cell leukemia cells. Leuk Res. 18, 79-84 (1994).
98. Musacchio, A. & Hardwick, K. G. The spindle checkpoint: structural insights into dynamic signalling. Nature Rev. Mol. Cell Biol. 3, 731-741 (2002).
99. Iwanaga, Y. et al. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res. 67, 160-166 (2007).
100. Michel, L. S. et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355-359 (2001).
101. Jin, D. Y., Spencer, F. & Jeang, K. T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93, 81-91 (1998).
102. Iwanaga, Y., Kasai, T., Kibler, K. & Jeang, K. T. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function. J. Biol. Chem. 277, 31005-31013 (2002).
103. Grimwade, D. et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92, 2322-2333 (1998).
104. Byrd, J. C. et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100, 4325-4336 (2002).
105. Liu, B., Hong, S., Tang, Z., Yu, H. & Giam, C. Z. HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule. Proc. Natl Acad. Sci. USA 102, 63-68 (2005).
106. Leao, M., Anderton, E., Wade, M., Meekings, K. & Allday, M. J. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells. J. Virol. 81, 248-260 (2007).
107. Marriott, S. J., Lemoine, F. J. & Jeang, K. T. Damaged DNA and miscounted chromosomes: human T cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells. J. Biomed. Sci. 9, 292-298 (2002).
108. Vafa, O. et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044 (2002).
109. Park, H. U., Jeong, J. H., Chung, J. H. & Brady, J. N. Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1. Oncogene 23, 4966-4974 (2004).
110. Haoudi, A. & Semmes, O. J. The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells. Virology 305, 229-239 (2003).
111. Jeang, K. T., Widen, S. G., Semmes, O. J. & Wilson, S. H. HTLV-I trans-activator protein, tax, is a transrepressor of the human beta-polymerase gene. Science 247, 1082-1084 (1990).
112. Philpott, S. M. & Buehring, G. C. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene. J. Natl Cancer Inst. 91, 933-942 (1999).
113. Kao, S. Y., Lemoine, F. J. & Marriott, S. J. p53-independent induction of apoptosis by the HTLV-I tax protein following UV irradiation. Virology 291, 292-298 (2001).
114. Morimoto, H., Tsukada, J., Kominato, Y. & Tanaka, Y. Reduced expression of human mismatch repair genes in adult T-cell leukemia. Am. J. Hematol. 78, 100-107 (2005).
115. Bellon, M. et al. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia. Int. J. Cancer 119, 2090-2097 (2006).
116. Gabet, A. S. et al. Inactivation of hTERT transcription by Tax. Oncogene 22, 3734-3741 (2003).
117. Majone, F. & Jeang, K. T. Clastogenic effect of the human T-cell leukemia virus type I Tax oncoprotein correlates with unstabilized DNA breaks. J. Biol. Chem. 275, 32906-32910 (2000).
118. Majone, F., Luisetto, R., Zamboni, D., Iwanaga, Y. & Jeang, K. T. Ku protein as a potential human T-cell leukemia virus type 1 (HTLV-1) Tax target in clastogenic chromosomal instability of mammalian cells. Retrovirology 2, 45 (2005).
119. Wilkie, A. O., Lamb, J., Harris, P. C., Finney, R. D. & Higgs, D. R. A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 346, 868-871 (1990).
120. Morin, G. B. Recognition of a chromosome truncation site associated with α-thalassaemia by human telomerase. Nature 353, 454-456 (1991).
121. Flint, J. et al. Healing of broken human chromosomes by the addition of telomeric repeats. Am. J. Hum. Genet. 55, 505-512 (1994).
122. Kubuki, Y. et al. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia. Leuk. Lymphoma 46, 393-399 (2005).
123. Uchida, N. et al. Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leuk. Res. 23, 311-316 (1999).
124. Tabakin-Fix, Y., Azran, I., Schavinky-Khrapunsky, Y., Levy, O. & Aboud, M. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis 27, 673-681 (2006).
125. Pise-Masison, C. A. et al. Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-κB pathway and is dependent on p53 phosphorylation. Mol. Cell Biol. 20, 3377-3386 (2000).
126. Ariumi, Y. et al. HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration. Oncogene 19, 1491-1499 (2000). References 125 and 126 provide insight into the inactivation of p53 by Tax.
127. Miyazato, A., Sheleg, S., Iha, H., Li, Y. & Jeang, K. T. Evidence for NFκB- and CBP-independent repression of p53's transcriptional activity by human T-cell leukemia virus type 1 Tax in mouse embryo and primary human fibroblasts. J. Virol. 79, 9346-9350 (2005).
128. Gaudray, G. et al. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 76, 12813-12822 (2002). This was the first conclusive report of an HBZ transcript in the antisense strand of the HTLV-1 genome.
129. Larocca, D., Chao, L. A., Seto, M. H. & Brunck, T. K. Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem. Biophys. Res. Commun. 163, 1006-1013 (1989).
130. Basbous, J. et al. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J. Biol. Chem. 278, 43620-43627 (2003).
131. Mesnard, J. M., Barbeau, B. & Devaux, C. HBZ, a new important player in the mystery of adult T-cell leukemia. Blood 108, 3979-3982 (2006).
132. Thebault, S., Basbous, J., Hivin, P., Devaux, C. & Mesnard, J. M. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 562, 165-170 (2004).
133. Cavanagh, M. H. et al. HTLV-I antisense transcripts initiating in the 3′LTR are alternatively spliced and polyadenylated. Retrovirology 3, 15 (2006).
134. Satoh, M. et al. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis. Oncogene 21, 2466-2475 (2002).
135. Satou, Y., Yasunaga, J., Yoshida, M. & Matsuoka, M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl Acad. Sci. USA 103, 720-725 (2006). Provided evidence that proliferative activity is supplied to virus infected cells through HBZ RNA.
136. Switzer, W. M. et al. Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J. Virol. 80, 7427-7438 (2006).
137. Arnold, J. et al. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107, 3976-3982 (2006).
138. Calin, G. A. et al. Frequent deletions and downregulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524-15529 (2002).
139. Yamada, Y. et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br. J. Haematol. 113, 375-382 (2001).
140. Mori, N. et al. Constitutive activation of NF-κB in primary adult T-cell leukemia cells. Blood 93, 2360-2368 (1999).
141. Satou, Y. et al. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 18, 1357-1363 (2004).
142. Watanabe, M. et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 106, 2462-2471 (2005).
143. Albert, J. M., Kim, K. W., Cao, C. & Lu, B. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol. Cancer Ther. 5, 1183-1189 (2006).
144. Luo, Y. et al. Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol. Cancer Ther. 4, 977-986 (2005).
145. Utsunomiya, A. et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27, 15-20 (2001).
146. Okamura, J. et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 105, 4143-4145 (2005).
147. Harashima, N. et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 64, 391-399 (2004).
148. Peloponese, J. M., Yeung, M. L. & Jeang, K. T. Modulation of nuclear factor-κB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol. Res. 34, 1-12 (2006).